Cardiac M2 muscarinic cholinoceptor activation by human chagasic autoantibodies: association with bradycardia
J C Goin, E S Borda, S Auger, R Storino, L Sterin-Borda
Centro de Estudios
Farmacológicos y Botánicos (CEFYBO), Pharmacology Department,
School of Medicine and Dentistry, University of Buenos Aires, Serrano
669, 5to Piso, 1414 Buenos Aires, Argentina
Correspondence to: Dr Sterin-Borda. email: leo{at}cefybo.edu.ar
Accepted for publication 2 November 1998
OBJECTIVE
To assess
whether exposure of cardiac muscarinic acetylcholine receptors (mAChR)
to activating chagasic antimyocardial immunoglobulins results in
bradycardia and other dysautonomic symptoms associated with the
regulation of heart rate.
METHODS
Trypanosoma
cruzi infected patients with bradycardia and other abnormalities
in tests of the autonomic nervous system were studied and compared with
normal subjects. Antipeptide antibodies in serum were demonstrated by
an enzyme linked immunosorbent assay using a synthetic 24-mer-peptide
corresponding antigenically to the second extracellular loop of the
human heart M2 mAChR. The functional effect of affinity
purified antipeptide IgG from chagasic patients on spontaneous beating
frequency and cAMP production of isolated normal rat atria was studied.
RESULTS
There
was a strong association between the finding of antipeptide antibodies
in chagasic patients and the presence of basal bradycardia and an
altered Valsalva manoeuvre (basal bradycardia:
2 = 37.5, p < 0.00001; Valsalva manoeuvre:
2 = 70.0, p < 0.00001). The antipeptide
autoantibodies also showed agonist activity, decreasing the rate of
contraction and cAMP production. The effects on rat atria resembled the
effects of the authentic agonist and those of the total polyclonal
chagasic IgG, being selectively blunted by atropine and AF-DX 116, and neutralised by the synthetic peptide corresponding in amino acid sequence to the second extracellular loop of the human M2 mAChR.
CONCLUSIONS
There is
an association between circulating antipeptide autoantibodies in
chagasic patients and the presence of bradycardia and other
dysautonomic symptoms. Thus these autoantibodies are a marker of
autoimmune cardiac autonomic dysfunction. The results support the
hypothesis that autoimmune mechanisms play a role in the pathogenesis
of chagasic cardioneuromyopathy.
Keywords: heart rate; bradycardia; autoantibodies; chagasic cardiomyopathy
© 1999 by Heart
This article has been cited by other articles:
-
Huang, X.-P., Prilla, S., Mohr, K., Ellis, J.
(2005). Critical Amino Acid Residues of the Common Allosteric Site on the M2 Muscarinic Acetylcholine Receptor: More Similarities than Differences between the Structurally Divergent Agents Gallamine and Bis(ammonio)alkane-Type Hexamethylene-bis-[dimethyl-(3-phthalimidopropyl)ammonium]dibromide. Mol. Pharmacol.
68: 769-778
[Abstract] [Full Text] -
Moses, P L, Ellis, L M, Anees, M R, Ho, W, Rothstein, R I, Meddings, J B, Sharkey, K A, Mawe, G M
(2003). Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease. Gut
52: 629-636
[Abstract] [Full Text] -
HAYWARD, M P
(1999). Dynamic cardiomyoplasty: time to wrap it up?. Heart
82: 263-264
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
